Genomtec S.A. (GMT) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.10x
Genomtec S.A. (GMT) has a Cash Flow Reinvestment Rate of 0.10x as of December 2024, reinvesting zł90.00K (capex zł45.00K plus investments zł-45.00K) from operating cash flow of zł925.00K. Explore how much does Genomtec S.A. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.10x
(Capex + Investments) / Operating CF
Total Reinvested
zł90.00K
Capex + Investments
Operating Cash Flow
zł925.00K
PLN
Capital Expenditures
zł45.00K
PLN
Annual Cash Flow Reinvestment Rate for Genomtec S.A. (None–None)
Year-by-year capital reinvestment analysis for Genomtec S.A.. For live market cap and broader valuation context, see GMT stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow